New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the

It seems ob­vi­ous to as­sume that pa­tient out-of-pock­et costs would in­crease as drug com­pa­nies raise the prices of their drugs. But a new study pub­lished